-DOCSTART- -X- O
We -X- _ O
investigated -X- _ O
the -X- _ O
clinical -X- _ O
manifestations -X- _ O
and -X- _ O
course -X- _ O
of -X- _ O
all -X- _ O
probable -X- _ O
severe -X- _ B-Intervention
acute -X- _ I-Intervention
respiratory -X- _ I-Intervention
syndrome -X- _ I-Intervention
( -X- _ I-Intervention
SARS -X- _ I-Intervention
) -X- _ I-Intervention
patients -X- _ B-Patient
in -X- _ I-Patient
the -X- _ I-Patient
Vietnam -X- _ I-Patient
outbreak. -X- _ O
Probable -X- _ O
SARS -X- _ O
cases -X- _ O
were -X- _ O
defined -X- _ O
by -X- _ O
using -X- _ O
the -X- _ O
revised -X- _ O
World -X- _ O
Health -X- _ O
Organization -X- _ O
criteria. -X- _ O
We -X- _ O
systematically -X- _ O
reviewed -X- _ O
medical -X- _ O
records -X- _ O
and -X- _ O
undertook -X- _ O
descriptive -X- _ O
statistical -X- _ O
analyses. -X- _ O
All -X- _ O
62 -X- _ B-Patient
patients -X- _ I-Patient
were -X- _ O
hospitalized. -X- _ O
On -X- _ O
admission -X- _ O
, -X- _ O
the -X- _ O
most -X- _ B-Outcome
prominent -X- _ I-Outcome
symptoms -X- _ I-Outcome
were -X- _ I-Outcome
malaise -X- _ I-Outcome
( -X- _ I-Outcome
82.3 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
fever -X- _ I-Outcome
( -X- _ I-Outcome
79.0 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Cough -X- _ I-Outcome
, -X- _ I-Outcome
chest -X- _ I-Outcome
pain -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
shortness -X- _ I-Outcome
of -X- _ I-Outcome
breath -X- _ I-Outcome
were -X- _ I-Outcome
present -X- _ I-Outcome
in -X- _ I-Outcome
approximately -X- _ I-Outcome
one -X- _ I-Outcome
quarter -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
patients -X- _ I-Outcome
; -X- _ I-Outcome
79.0 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
lymphopenia -X- _ I-Outcome
; -X- _ I-Outcome
40.3 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
thrombocytopenia -X- _ I-Outcome
; -X- _ I-Outcome
19.4 -X- _ I-Outcome
% -X- _ I-Outcome
had -X- _ I-Outcome
leukopenia -X- _ I-Outcome
; -X- _ I-Outcome
and -X- _ I-Outcome
75.8 -X- _ I-Outcome
% -X- _ I-Outcome
showed -X- _ I-Outcome
changes -X- _ I-Outcome
on -X- _ I-Outcome
chest -X- _ I-Outcome
radiograph. -X- _ I-Outcome
Fever -X- _ I-Outcome
developed -X- _ I-Outcome
on -X- _ I-Outcome
the -X- _ I-Outcome
first -X- _ I-Outcome
day -X- _ I-Outcome
of -X- _ I-Outcome
illness -X- _ I-Outcome
onset -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
both -X- _ I-Outcome
respiratory -X- _ I-Outcome
symptoms -X- _ I-Outcome
and -X- _ I-Outcome
radiographic -X- _ I-Outcome
changes -X- _ I-Outcome
occurred -X- _ I-Outcome
on -X- _ I-Outcome
day -X- _ I-Outcome
4. -X- _ I-Outcome
On -X- _ I-Outcome
average -X- _ I-Outcome
, -X- _ I-Outcome
maximal -X- _ I-Outcome
radiographic -X- _ I-Outcome
changes -X- _ I-Outcome
were -X- _ I-Outcome
observed -X- _ I-Outcome
on -X- _ I-Outcome
day -X- _ I-Outcome
10 -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
fevers -X- _ I-Outcome
subsided -X- _ I-Outcome
by -X- _ I-Outcome
day -X- _ I-Outcome
13. -X- _ I-Outcome
Symptoms -X- _ I-Outcome
on -X- _ I-Outcome
admission -X- _ I-Outcome
were -X- _ I-Outcome
nonspecific -X- _ I-Outcome
, -X- _ I-Outcome
although -X- _ I-Outcome
fever -X- _ I-Outcome
, -X- _ I-Outcome
malaise -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
lymphopenia -X- _ I-Outcome
were -X- _ I-Outcome
common. -X- _ I-Outcome
The -X- _ I-Outcome
complications -X- _ I-Outcome
of -X- _ I-Outcome
SARS -X- _ I-Outcome
included -X- _ I-Outcome
invasive -X- _ I-Outcome
intubation -X- _ I-Outcome
and -X- _ I-Outcome
ventilation -X- _ I-Outcome
( -X- _ I-Outcome
11.3 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
death -X- _ I-Outcome
( -X- _ I-Outcome
9.7 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O

